20.07.2020 • NewsPerstorpJan SecherPeople

Perstorp Appoints Ulf Berghult as New CFO

Ulf Berghult has been appointed as Perstorp’s new CFO as of mid-February. He joins the group from Trelleborg, where he held the position as CFO since 2012.

Previous experience includes similar positions at companies like Thule, Dometic and Oriflame.

Berghult holds a BSc in Business Administration from Lund University, Sweden and will be based at Perstorp’s head office in Malmö.

“I am excited to join Perstorp, which is a successful company with a long history and leading market positions in the specialty chemicals industry. I have been impressed by the professional and open spirit I have met, and I look very much forward to be part of the team and contribute with my experience”, said Berghult.

“It is very important that we can secure continuity in the CFO office, especially in these uncertain times. I am therefore very pleased to welcome Ulf Berghult, with his vast experience, to join us during this period. Ulf has relevant industrial experience and a proven track record of successfully having managed businesses in various stages, ownership and level of complexity. He will bring valuable and fresh perspectives from his previous positions”, says Jan Secher, President & CEO at Perstorp.

Ulf Berghult has been appointed as Perstorp’s new CFO as of mid-February. (c)...
Ulf Berghult has been appointed as Perstorp’s new CFO as of mid-February. (c) Perstorp

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read